CHRISTINE VU: Open Payments
NPI 1588083190 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 14 payments from 9 companies in 2025. Trend: 2023 $910 · 2024 $1,366 · 2025 $1,616
Food & beverage: $1,616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $482 |
| Kerecis Limited | 1 | $257 |
| Amgen Inc. | 1 | $142 |
| Organogenesis Inc. | 1 | $140 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $135 |
| Eisai Inc. | 1 | $124 |
| GENZYME CORPORATION | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Ethicon US, LLC | 1 | $93 |
Products named: NATRELLE SALINE-FILLED BREAST IMPLANTS, Kerecis SurgiClose, TEPEZZA, PURAPLY WOUND MATRIX, ALLODERM, Leqembi, DUPIXENT, STRATAFIX.
Industry payments across TX — which companies pay providers there.
